United States · FDA National Drug Code directory
QC Triple Antibiotic
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 83324-050_1a14f49a-8fbc-4b14-e063-6394a90a817b
- Product NDC
- 83324-050
- Form
- OINTMENT
- Composition / generic term
- Bacitracin zinc, Neomycin sulfate , Polymyxin B sulfate.
- Labeler
- Chain Drug Marketing Association
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20240315
- Source listing expiry
- 20261231
Source-listed ingredients
- BACITRACIN ZINC — 400 [USP'U]/g
- NEOMYCIN SULFATE — 3.5 mg/g
- POLYMYXIN B SULFATE — 5000 [USP'U]/g
These values do not establish equivalence or a dose recommendation.
Packages
- 1 TUBE in 1 BOX (83324-050-01) / 28.3 g in 1 TUBE · 83324-050-01
- 1 TUBE in 1 BOX (83324-050-05) / 14.2 g in 1 TUBE · 83324-050-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →